journal article·2023

Cascade strategy for glucose oxidase-based synergistic cancer therapy using nanomaterials

Ruixuan He, Peida Yang, Aoxue Liu, Yueli Zhang, Yuqi Chen, Cong Chang, Bo Lu

Journal of Materials Chemistry B· Volume 11· Issue 41
Publisher page

Abstract

Nanomaterial-based cancer therapy faces significant limitations due to the complex nature of the tumor microenvironment (TME). Starvation therapy is an emerging therapeutic approach that targets tumor cell metabolism using glucose oxidase (GOx). Importantly, it can provide a material or environmental foundation for other diverse therapeutic methods by manipulating the properties of the TME, such as acidity, hydrogen peroxide (H2O2) levels, and hypoxia degree. In recent years, this cascade strategy has been extensively applied in nanoplatforms for ongoing synergetic therapy and still holds undeniable potential. However, only a few review articles comprehensively elucidate the rational designs of nanoplatforms for synergetic therapeutic regimens revolving around the conception of the cascade strategy. Therefore, this review focuses on innovative cascade strategies for GOx-based synergetic therapy from representative paradigms to state-of-the-art reports to provide an instructive, comprehensive, and insightful reference for readers. Thereafter, we discuss the remaining challenges and offer a critical perspective on the further advancement of GOx-facilitated cancer treatment toward clinical translation.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan 430070, People's Republic of China

College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China

Funding

National Natural Science Foundation of China · National College Students Innovation and Entrepreneurship Training Program · Hubei Provincial Department of Education

References (100+)

Show source-provided references
1. Siegel · Ca-Cancer J. Clin. · 2022 · 72 · 710.3322/caac.21708 ↗
2. Siegel · Ca-Cancer J. Clin. · 2023 · 73 · 1710.3322/caac.21763 ↗
3. Zeng · Mol. Cancer · 2023 · 22 · 1010.1186/s12943-022-01708-4 ↗
4. Kong · Prog. Mater. Sci. · 2023 · 134 · 10107010.1016/j.pmatsci.2023.101070 ↗
5. Tian · Pharmacol. Res. · 2022 · 178 · 10618410.1016/j.phrs.2022.106184 ↗
6. Zhao · Angew. Chem., Int. Ed. · 2023 · 62 · e20221041510.1002/anie.202210415 ↗
7. Ding · Coord. Chem. Rev. · 2022 · 464 · 21456410.1016/j.ccr.2022.214564 ↗
8. Algorri · Cancers · 2021 · 13 · 444710.3390/cancers13174447 ↗
9. Yu · Theranostics · 2019 · 9 · 802610.7150/thno.38261 ↗
10. Meng · Mater. Today Bio · 2020 · 7 · 10005610.1016/j.mtbio.2020.100056 ↗
11. Yang · Pharmacol. Res. · 2017 · 126 · 9710.1016/j.phrs.2017.05.004 ↗
12. Xia · Front. Oncol. · 2022 · 12 · 108944610.3389/fonc.2022.1089446 ↗
13. Zhao · Nanoscale · 2020 · 12 · 285510.1039/C9NR09071A ↗
14. Shim · Adv. Drug Delivery Rev. · 2017 · 115 · 5710.1016/j.addr.2017.04.003 ↗
15. Chen · Chem. Soc. Rev. · 2020 · 49 · 905710.1039/D0CS00607F ↗
16. Yao · Biomater. Sci. · 2022 · 10 · 400810.1039/D2BM00595F ↗
17. Yang · Adv. Mater. · 2019 · 31 · 190177810.1002/adma.201901778 ↗
18. Fu · Chem. Soc. Rev. · 2018 · 47 · 645410.1039/C7CS00891K ↗
19. Wang · Small · 2019 · 15 · 190389510.1002/smll.201903895 ↗
20. Li · Int. J. Nanomed. · 2022 · 17 · 270710.2147/IJN.S364840 ↗
21. Tang · J. Mater. Chem. B · 2021 · 9 · 574910.1039/D1TB00218J ↗
22. Fu · Adv. Mater. · 2019 · 31 · 180832510.1002/adma.201808325 ↗
23. Abdel-Wahab · Pharmacol. Res. · 2019 · 150 · 10451110.1016/j.phrs.2019.104511 ↗
24. Yang · Chem. Rev. · 2019 · 119 · 488110.1021/acs.chemrev.8b00626 ↗
25. Wang · Adv. Ther. · 2020 · 3 · 200011010.1002/adtp.202000110 ↗
26. Zhang · Biomaterials · 2021 · 275 · 12098710.1016/j.biomaterials.2021.120987 ↗
27. Zhang · Small · 2018 · 14 · 180360210.1002/smll.201803602 ↗
28. Zhang · Matter · 2021 · 4 · 2610.1016/j.matt.2020.10.002 ↗
29. Tekade · Drug Discovery Today · 2017 · 22 · 163710.1016/j.drudis.2017.08.003 ↗
30. Zhang · Nano Res. · 2022 · 15 · 526210.1007/s12274-022-4165-1 ↗
31. Yi · Eur. J. Med. Chem. · 2022 · 247 · 11508410.1016/j.ejmech.2022.115084 ↗
32. Yu · Biomaterials · 2022 · 280 · 12130810.1016/j.biomaterials.2021.121308 ↗
33. Xiao · Angew. Chem., Int. Ed. · 2022 · 61 · e20220458410.1002/anie.202204584 ↗
34. Ma · ACS Nano · 2019 · 13 · 889010.1021/acsnano.9b02466 ↗
35. Ming · ACS Appl. Mater. Interfaces · 2020 · 12 · 5124910.1021/acsami.0c15211 ↗
36. Zhou · Adv. Mater. · 2022 · 34 · 220087110.1002/adma.202200871 ↗
37. Cui · Catal. Sci. Technol. · 2019 · 9 · 47710.1039/C8CY01945B ↗
38. Mu · Chem. Eng. J. · 2023 · 451 · 13855410.1016/j.cej.2022.138554 ↗
39. Wang · ACS Appl. Mater. Interfaces · 2022 · 14 · 4402910.1021/acsami.2c09947 ↗
40. Xu · Small · 2022 · 18 · 220340010.1002/smll.202203400 ↗
41. Zhang · Mater. Des. · 2022 · 222 · 11106710.1016/j.matdes.2022.111067 ↗
42. Lyu · Adv. Healthcare Mater. · 2020 · 9 · 190181910.1002/adhm.201901819 ↗
43. Yang · Chem. Eng. J. · 2021 · 409 · 12738110.1016/j.cej.2020.127381 ↗
44. Su · ACS Appl. Mater. Interfaces · 2021 · 13 · 1296010.1021/acsami.1c02011 ↗
45. Lu · Adv. Sci. · 2020 · 7 · 200122310.1002/advs.202001223 ↗
46. Li · Adv. Funct. Mater. · 2020 · 30 · 190771610.1002/adfm.201907716 ↗
47. Yan · Small · 2019 · 15 · 190301610.1002/smll.201903016 ↗
48. Ding · Nano Res. · 2021 · 15 · 155410.1007/s12274-021-3701-8 ↗
49. Wu · Chem. Soc. Rev. · 2019 · 48 · 100410.1039/C8CS00457A ↗
50. Huang · Chem. Rev. · 2019 · 119 · 435710.1021/acs.chemrev.8b00672 ↗
51. Bintang Ilhami · Polym. Chem. · 2020 · 11 · 84910.1039/C9PY01557D ↗
52. Mi · Theranostics · 2020 · 10 · 455710.7150/thno.38069 ↗
53. Wen · Chem. Soc. Rev. · 2017 · 46 · 602410.1039/C7CS00219J ↗
54. Tang · Theranostics · 2020 · 10 · 869110.7150/thno.45392 ↗
55. Hu · Biomater. Sci. · 2022 · 10 · 235810.1039/D1BM01944A ↗
56. Schwartz · Semin. Cancer Biol. · 2017 · 43 · 13410.1016/j.semcancer.2017.01.005 ↗
57. Lu · Biomaterials · 2022 · 290 · 12185210.1016/j.biomaterials.2022.121852 ↗
58. Xu · Microporous Mesoporous Mater. · 2020 · 303 · 11025910.1016/j.micromeso.2020.110259 ↗
59. Dominski · Pharmaceutics · 2022 · 14 · 29010.3390/pharmaceutics14020290 ↗
60. Ailincai · Carbohydr. Polym. · 2022 · 298 · 12007110.1016/j.carbpol.2022.120071 ↗
61. Han · J. Drug Delivery Sci. Technol. · 2022 · 75 · 10361010.1016/j.jddst.2022.103610 ↗
62. Reshmi · J. Drug Delivery Sci. Technol. · 2023 · 79 · 10409810.1016/j.jddst.2022.104098 ↗
63. Sahkulubey Kahveci · Biomacromolecules · 2022 · 23 · 489610.1021/acs.biomac.2c01076 ↗
64. Liu · Adv. Healthcare Mater. · 2020 · 9 · 200043210.1002/adhm.202000432 ↗
65. Ren · ACS Appl. Mater. Interfaces · 2020 · 12 · 3466710.1021/acsami.0c09489 ↗
66. Zhuang · ACS Appl. Nano Mater. · 2021 · 4 · 1148010.1021/acsanm.1c01588 ↗
67. Zhou · Adv. Healthcare Mater. · 2021 · 10 · 200127710.1002/adhm.202001277 ↗
68. Thomas · Front. Mol. Biosci. · 2020 · 7 · 61053310.3389/fmolb.2020.610533 ↗
69. Zhou · J. Controlled Release · 2018 · 288 · 1410.1016/j.jconrel.2018.08.036 ↗
70. Rashed · Redox Biol. · 2022 · 52 · 10230010.1016/j.redox.2022.102300 ↗
71. Li · Angew. Chem., Int. Ed. · 2020 · 59 · 2254410.1002/anie.202004008 ↗
72. Yu · Proc. Natl. Acad. Sci. U. S. A. · 2015 · 112 · 826010.1073/pnas.1505405112 ↗
73. Liang · Bioeng. Transl. Med. · 2016 · 1 · 23910.1002/btm2.10014 ↗
74. Kirtonia · Cell. Mol. Life Sci. · 2020 · 77 · 445910.1007/s00018-020-03536-5 ↗
75. Daund · J. Drug Delivery Sci. Technol. · 2021 · 64 · 10259910.1016/j.jddst.2021.102599 ↗
76. Li · Nano Lett. · 2017 · 17 · 698310.1021/acs.nanolett.7b03531 ↗
77. Li · ACS Nano · 2022 · 16 · 1498210.1021/acsnano.2c06026 ↗
78. Liu · Angew. Chem., Int. Ed. · 2022 · 61 · e20211680710.1002/anie.202116807 ↗
79. Stella · Expert Opin. Ther. Pat. · 2005 · 14 · 27710.1517/13543776.14.3.277 ↗
80. Zhang · Adv. Sci. · 2021 · 8 · 210145410.1002/advs.202101454 ↗
81. Najjar · Molecules · 2020 · 25 · 88410.3390/molecules25040884 ↗
82. Lindsay · PLoS Comput. Biol. · 2016 · 12 · e100507710.1371/journal.pcbi.1005077 ↗
83. Chmielecki · Sci. Transl. Med. · 2011 · 3 · 90ra5910.1126/scitranslmed.3002356 ↗
84. Zhang · Chem. Eng. J. · 2023 · 458 · 14151010.1016/j.cej.2023.141510 ↗
85. Li · Front. Oncol. · 2021 · 11 · 70040710.3389/fonc.2021.700407 ↗
86. Zhang · Biomaterials · 2018 · 162 · 12310.1016/j.biomaterials.2018.02.004 ↗
87. Yang · Adv. Funct. Mater. · 2018 · 28 · 180070610.1002/adfm.201800706 ↗
88. Zhang · ACS Nano · 2018 · 12 · 1020110.1021/acsnano.8b05200 ↗
89. Shan · ACS Nano · 2019 · 13 · 890310.1021/acsnano.9b02477 ↗
90. Shao · Biomaterials · 2021 · 274 · 12086910.1016/j.biomaterials.2021.120869 ↗
91. Hang · Theranostics · 2021 · 11 · 1000110.7150/thno.65399 ↗
92. Mei · Mater. Horiz. · 2020 · 7 · 183410.1039/D0MH00105H ↗
93. Wang · J. Controlled Release · 2021 · 333 · 50010.1016/j.jconrel.2021.04.007 ↗
94. Cheng · Biomaterials · 2019 · 195 · 7510.1016/j.biomaterials.2019.01.003 ↗
95. Ding · Acta Biomater. · 2022 · 146 · 39610.1016/j.actbio.2022.04.027 ↗
96. Zhang · Angew. Chem., Int. Ed. · 2022 · 61 · e20220858310.1002/anie.202208583 ↗
97. Zalba · J. Controlled Release · 2022 · 351 · 2210.1016/j.jconrel.2022.09.002 ↗
98. Liu · Biomaterials · 2016 · 83 · 5110.1016/j.biomaterials.2016.01.008 ↗
99. Hama · J. Controlled Release · 2015 · 206 · 6710.1016/j.jconrel.2015.03.011 ↗
100. Fang · Drug Delivery · 2017 · 24 · 2210.1080/10717544.2017.1388451 ↗